147 related articles for article (PubMed ID: 28127057)
1. Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2.
Zhang M; Pan Y; Dorfman RG; Yin Y; Zhou Q; Huang S; Liu J; Zhao S
Sci Rep; 2017 Feb; 7(1):7. PubMed ID: 28127057
[TBL] [Abstract][Full Text] [Related]
2. SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice.
Ren YR; Ye YL; Feng Y; Xu TF; Shen Y; Liu J; Huang SL; Shen JH; Leng Y
Acta Pharmacol Sin; 2021 Nov; 42(11):1834-1846. PubMed ID: 33574568
[TBL] [Abstract][Full Text] [Related]
3. Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.
Jiang W; Wang S; Xiao M; Lin Y; Zhou L; Lei Q; Xiong Y; Guan KL; Zhao S
Mol Cell; 2011 Jul; 43(1):33-44. PubMed ID: 21726808
[TBL] [Abstract][Full Text] [Related]
4. Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3.
Zhang B; Pan Y; Xu L; Tang D; Dorfman RG; Zhou Q; Yin Y; Li Y; Zhou L; Zhao S; Zou X; Wang L; Zhang M
Endocrine; 2018 Dec; 62(3):576-587. PubMed ID: 30117113
[TBL] [Abstract][Full Text] [Related]
5. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.
Peck B; Chen CY; Ho KK; Di Fruscia P; Myatt SS; Coombes RC; Fuchter MJ; Hsiao CD; Lam EW
Mol Cancer Ther; 2010 Apr; 9(4):844-55. PubMed ID: 20371709
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II induces microtubule reorganization mediated by a deacetylase SIRT2 in endothelial cells.
Hashimoto-Komatsu A; Hirase T; Asaka M; Node K
Hypertens Res; 2011 Aug; 34(8):949-56. PubMed ID: 21677656
[TBL] [Abstract][Full Text] [Related]
7. Dichloroacetic acid (DCA) synergizes with the SIRT2 inhibitor Sirtinol and AGK2 to enhance anti-tumor efficacy in non-small cell lung cancer.
Ma W; Zhao X; Wang K; Liu J; Huang G
Cancer Biol Ther; 2018; 19(9):835-846. PubMed ID: 30067423
[TBL] [Abstract][Full Text] [Related]
8. PEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed Rats.
Beddow SA; Gattu AK; Vatner DF; Paolella L; Alqarzaee A; Tashkandi N; Popov VB; Church CD; Rodeheffer MS; Cline GW; Geisler JG; Bhanot S; Samuel VT
Endocrinology; 2019 Jan; 160(1):205-219. PubMed ID: 30445425
[TBL] [Abstract][Full Text] [Related]
9. SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism.
Li Y; Zhang M; Dorfman RG; Pan Y; Tang D; Xu L; Zhao Z; Zhou Q; Zhou L; Wang Y; Yin Y; Shen S; Kong B; Friess H; Zhao S; Wang L; Zou X
Neoplasia; 2018 Jul; 20(7):745-756. PubMed ID: 29925042
[TBL] [Abstract][Full Text] [Related]
10. PCK1 Protects against Mitoribosomal Defects in Diabetic Nephropathy in Mouse Models.
Hasegawa K; Sakamaki Y; Tamaki M; Wakino S
J Am Soc Nephrol; 2023 Aug; 34(8):1343-1365. PubMed ID: 37199399
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors.
Mai A; Massa S; Lavu S; Pezzi R; Simeoni S; Ragno R; Mariotti FR; Chiani F; Camilloni G; Sinclair DA
J Med Chem; 2005 Dec; 48(24):7789-95. PubMed ID: 16302818
[TBL] [Abstract][Full Text] [Related]
12. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.
Yu J; Wu Y; Yang P
J Neurochem; 2016 May; 137(3):371-83. PubMed ID: 26896748
[TBL] [Abstract][Full Text] [Related]
13. Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.
Bian XL; Chen HZ; Yang PB; Li YP; Zhang FN; Zhang JY; Wang WJ; Zhao WX; Zhang S; Chen QT; Zheng Y; Sun XY; Wang XM; Chien KY; Wu Q
Nat Commun; 2017 Feb; 8():14420. PubMed ID: 28240261
[TBL] [Abstract][Full Text] [Related]
14. Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice.
Tanaka H; Nagashima T; Shimaya A; Urano Y; Shimokawa T; Shibasaki M
Eur J Pharmacol; 2010 Oct; 645(1-3):185-91. PubMed ID: 20655898
[TBL] [Abstract][Full Text] [Related]
15. The sirtuin inhibitor cambinol impairs MAPK signaling, inhibits inflammatory and innate immune responses and protects from septic shock.
Lugrin J; Ciarlo E; Santos A; Grandmaison G; dos Santos I; Le Roy D; Roger T
Biochim Biophys Acta; 2013 Jun; 1833(6):1498-510. PubMed ID: 23499872
[TBL] [Abstract][Full Text] [Related]
16. Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats.
Prasath GS; Pillai SI; Subramanian SP
Eur J Pharmacol; 2014 Oct; 740():248-54. PubMed ID: 25064342
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.
Suzuki T; Khan MN; Sawada H; Imai E; Itoh Y; Yamatsuta K; Tokuda N; Takeuchi J; Seko T; Nakagawa H; Miyata N
J Med Chem; 2012 Jun; 55(12):5760-73. PubMed ID: 22642300
[TBL] [Abstract][Full Text] [Related]
18. Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein.
Watanabe H; Inaba Y; Kimura K; Matsumoto M; Kaneko S; Kasuga M; Inoue H
Nat Commun; 2018 Jan; 9(1):30. PubMed ID: 29296001
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentration-dependent modulation of multiple nuclear receptor-mediated pathways in androgen-responsive prostate cancer cell LNCaP.
Wang TT; Schoene NW; Kim EK; Kim YS
Mol Carcinog; 2013 Sep; 52(9):676-85. PubMed ID: 22495798
[TBL] [Abstract][Full Text] [Related]
20. Discovery and validation of SIRT2 inhibitors based on tenovin-6: use of a ¹H-NMR method to assess deacetylase activity.
Pirrie L; McCarthy AR; Major LL; Morkūnaitė V; Zubrienė A; Matulis D; Lain S; Lebl T; Westwood NJ
Molecules; 2012 Oct; 17(10):12206-24. PubMed ID: 23079492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
